Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travatan versus Cosopt in open-angle glaucoma or ocular hypertension
2006-000071-15Phase 4Terminated
- Sponsor
- Alcon Inc.
- Start
- Sep 2006
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of travoprost and dorzolamide in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Alcon Inc. Started Sep 2006; status: terminated.
02
Drugs
travoprostdorzolamide
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2006-000071-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000071-15.